Q-omics provides the consensus-scored MIR466 profile across patient tissues and cancer cell-line models. MIR466 expression is associated with patient survival in 3 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MIR466 RNA expression shows 7,375 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight STAD, and COAD as cancer lineages where MIR466 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.